Printed from https://fyi.org.nz/request/3931-fatalities-and-adverse-reactions-to-statins-in-new-zealand?unfold=1 on November 22, 2024 10:37

Fatalities and adverse reactions to statins in New Zealand

Heather Barker made this Official Information request to University of Otago

The request was successful.

From: Heather Barker

Dear University of Otago,

Further to a previous request I would like to update the number of
adverse reactions to all brands of statins including fatalities in the
period February 2015- February 2016.

Yours faithfully,

Heather Barker

Link to this

From: Janelle Ashton
University of Otago

Attachment OIA Statins 2016.pdf
52K Download View as HTML

Heather Barker

In response to your OIA request to the University of Otago which has been
referred onto CARM for action, I am providing the attached document
detailing the updated information.

 

Janelle Ashton | Manager Information Systems | New Zealand
Pharmacovigilance Centre [ [1]https://nzphvc.otago.ac.nz ]

NZPhvC, PO Box 913, Dunedin 9054, New Zealand | DDI: +64-3-479 9043 | Fax:
+64-3-479 7150 | [2][email address]

 

 

 

-----Original Message-----
From: University of Otago Registrar
Sent: Wednesday, 27 April 2016 9:28 a.m.
To: Michael Tatley
Cc: Janelle Ashton
Subject: FW: Official Information Act request - Fatalities and adverse
reactions to statins in New Zealand

 

Dear Michael,

 

Please see below an Official Information Request from Heather Barker which
came via the FYI website.

 

I would be grateful if you could provide Ms Barker with the requested
information and copy me in on your response.

 

I have attached the documentation that you provided to Ms Barker last year
for ease of reference.

 

With kind regards,

 

Jan Flood

 

 

 

-----Original Message-----

From: Heather Barker
[[3]mailto:[FOI #3931 email]]

Sent: Wednesday, 27 April 2016 6:22 a.m.

To: University of Otago Registrar <[4][University of Otago request email]>

Subject: Official Information Act request - Fatalities and adverse
reactions to statins in New Zealand

 

Dear University of Otago,

 

Further to a previous request I would like to update the number of adverse
reactions to all brands of statins including fatalities in the period
February 2015- February 2016.

 

Yours faithfully,

 

Heather Barker

 

-------------------------------------------------------------------

 

This is an OIA request done via the FYI website.

 

Please do not send progress updates as PDF files.

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[5]https://fyi.org.nz/help/officers

 

If you find this service useful as an OIA officer, please ask your web
manager to link to us from your organisation's OIA page.

 

 

-------------------------------------------------------------------

References

Visible links
1. https://nzphvc.otago.ac.nz/
2. mailto:[email address]
3. mailto:[FOI #3931 email]
4. mailto:[University of Otago request email]
5. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

From: Heather Barker

Dear Janelle Ashton,

Thank you for your prompt response to my request about statins. It was pleasing to note only an additional 22 adverse reactions were reported to CARM, although I feel this is not a true representation of what actually happens. I know of several people in the last year who had to stop statins because of severe effects and to my knowledge none of these incidents were submitted. One friend was told by their GP there was no need to submit to CARM as the 'side effects are well known' and therefore not unusual so didn't warrant the time to fill in a report.

This continues to be a concern to me - and of course, we have no real method to view the long term injury of people who had severe reactions. My husband continues to have extremely ill health due to muscle wasting, fatigue and peripheral neuropathy since his acute renal failure in 2002.

Yours sincerely,

Heather Barker

Link to this

Things to do with this request

Anyone:
University of Otago only: